phenelzine has been researched along with Narcolepsy in 2 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murphy, DL | 1 |
Sunderland, T | 1 |
Cohen, RM | 1 |
Wyatt, RJ | 1 |
Fram, DH | 1 |
Buchbinder, R | 1 |
Snyder, F | 1 |
1 review available for phenelzine and Narcolepsy
Article | Year |
---|---|
Monoamine oxidase-inhibiting antidepressants. A clinical update.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Diet; Drug Interactions; D | 1984 |
1 trial available for phenelzine and Narcolepsy
Article | Year |
---|---|
Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
Topics: Adult; Cataplexy; Clinical Trials as Topic; Dreams; Edema; Electroencephalography; Electromyography; | 1971 |